Online citations, reference lists, and bibliographies.
← Back to Search

Malignant Mesothelioma Of The Pleura.

R. J. Pisani, T. Colby, D. Williams
Published 1988 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Malignant mesothelioma of the pleura most commonly occurs in persons with a heavy occupational exposure to asbestos. Some patients, however, have no such history of exposure. Clinical features include initial complaints of nonpleuritic chest pain and dyspnea. The most frequent roentgenographic finding is a unilateral pleural effusion. Thrombocytosis and elevated erythrocyte sedimentation rates are common. Pleural effusions are typically exudates, are often hemorrhagic, and are usually insufficient for diagnosing mesothelioma based on cytology alone. Even pleural biopsy may not produce enough tissue to enable the pathologist to make a firm diagnosis. Thoracotomy and open biopsy will confirm the diagnosis in most cases. Pathologic distinction from metastatic adenocarcinoma may be difficult even after the use of special stains and electron microscopy. Clinical deterioration is primarily attributable to local spread of tumor. Several factors seem to predict prolonged survival: (1) epithelial histologic subtype, (2) performance score, (3) age of the patient at the time of diagnosis, and (4) absence of chest pain. Surgical treatment, chemotherapy, and irradiation, alone or in combination, have been used for malignant mesothelioma. Except for the palliative effect of irradiation, most treatment protocols have not altered the dismal median survival of approximately 11 months seen in untreated patients with malignant mesothelioma.
This paper references
10.1016/s0169-5002(87)80457-9
The diagnostic distinction between malignant mesothelioma of the pleura and adenocarcinoma of the lung as defined by a monoclonal antibody (B72.3).
C. Szpak (1986)
10.1016/S0140-6736(78)90911-X
NON-OCCUPATIONAL EXPOSURE TO ASBESTOS AND MALIGNANT MESOTHELIOMA IN FEMALES
N. Vianna (1978)
Malignant mesotheliomas. Improved differential diagnosis from lung adenocarcinomas using monoclonal antibodies 44-3A6 and 624A12.
I. Lee (1986)
10.1016/S0140-6736(87)90305-9
ASSOCIATION OF METSOVO LUNG AND PLEURAL MESOTHELIOMA WITH EXPOSURE TO TREMOLITE-CONTAINING WHITEWASH
A. Langer (1987)
10.1136/thx.39.4.255
Malignant mesothelioma of the pleura: a study of 52 treated and 64 untreated patients.
M. Law (1984)
10.1002/1097-0142(19801215)46:12<2736::AID-CNCR2820461233>3.0.CO;2-L
Latency of asbestos disease among insulation workers in the United States and Canada
I. Selikoff (1980)
Letter: Parkinsonism induced by fluphenazine decanoate.
P. Lamb (1976)
10.1136/jcp.40.1.19
Immunohistological staining of reactive mesothelium, mesothelioma, and lung carcinoma with a panel of monoclonal antibodies.
A. Ghosh (1987)
10.1056/NEJM196503182721104
RELATION BETWEEN EXPOSURE TO ASBESTOS AND MESOTHELIOMA.
I. Selikoff (1965)
10.5555/URI:PII:0093775481900403
Clinical presentation and natural history of benign and malignant mesothelioma.
K. Antman (1981)
10.1016/0002-9343(80)90103-5
Multimodality therapy for malignant mesothelioma based on a study of natural history.
K. H. Antman (1980)
10.1016/0007-0971(83)90068-2
Malignant mesothelioma 1982: review of 4710 published cases.
G. Hillerdal (1983)
Mesothelioma: Diagnosis and management
C. Kittle (1987)
10.1016/s0169-5002(87)80458-0
Antigenic phenotype of malignant mesotheliomas and pulmonary adenocarcinomas. An immunohistologic analysis demonstrating the value of Leu M1 antigen.
K. Sheibani (1986)
10.1016/0007-0971(81)90027-9
Diffuse malignant pleural mesothelioma in Glasgow.
A. J. Dorward (1981)
Mesotheliomas of peritoneum, epicardium, and pericardium induced by strain MC29 avian leukosis virus.
J. F. Chabot (1970)
10.1200/JCO.1988.6.1.147
Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965-1985.
K. Antman (1988)
10.1200/JCO.1987.5.1.86
Randomized comparison of cyclophosphamide, imidazole carboxamide, and adriamycin versus cyclophosphamide and adriamycin in patients with advanced stage malignant mesothelioma: a Sarcoma Intergroup Study.
M. Samson (1987)
10.1111/j.1749-6632.1979.tb18705.x
LONG‐TERM MORTALITY EXPERIENCE OF CHRYSOTILE MINERS AND MILLERS IN THETFORD MINES, QUEBEC *
William J. Nicholson (1979)
10.1136/thx.26.1.6
Diffuse malignant pleural mesothelioma and asbestos exposure
F. Whitwell (1971)
10.1038/BJC.1973.134
Mesotheliomata in Rats after Inoculation with Asbestos and Other Materials
J. Wagner (1973)
10.1002/1097-0142(197010)26:4<914::AID-CNCR2820260427>3.0.CO;2-H
Epidemiology of primary malignant mesothelial tumors in canada
A. McDonald (1970)
10.1002/1097-0142(197910)44:4<1465::AID-CNCR2820440441>3.0.CO;2-Y
Localized primary tumors of the pleura. An analysis of 40 cases
W. Dalton (1979)
10.1002/1097-0142(19861001)58:7<1540::AID-CNCR2820580727>3.0.CO;2-5
Diffuse malignant mesothelioma of pleura: Diagnosis and survival in 92 cases
V. Adams (1986)
10.1001/JAMA.1982.03320300021016
Prevalence and incidence of benign asbestos pleural effusion in a working population.
G. Epler (1982)
10.1111/j.1365-2559.1986.tb02584.x
Solitary (localized) fibrous mesothelioma: evidence against mesothelial cell origin
P. Dervan (1986)
Mesothelioma associated with the shipbuilding industry in coastal Virginia.
I. Tagnon (1980)
10.1002/PATH.1700930204
A primary mesothelioma involving the rectovaginal septum and associated with beryllium.
C. Gold (1967)
10.1378/CHEST.93.3.621
Chrysotile, tremolite, and malignant mesothelioma in man.
A. Churg (1988)
10.1093/JNCI/79.4.797
Pleural carcinogenic potency of mineral fibers (asbestos, attapulgite) and their cytotoxicity on cultured cells.
M. Jaurand (1987)
10.1002/1097-0142(19810601)47:11<2678::AID-CNCR2820471126>3.0.CO;2-9
Solitary fibrous tumors of the pleura: Eight new cases and review of 360 cases in the literature
M. Briselli (1981)
Diagnosis and prognosis in malignant pleural mesothelioma: a prospective study.
G. Mårtensson (1984)
10.1136/jcp.37.11.1215
Use of antibodies to carcinoembryonic antigen and human milk fat globule to distinguish carcinoma, mesothelioma, and reactive mesothelium.
R. J. Marshall (1984)
Mesothelioma: profile of keratin proteins and carcinoembryonic antigen: an immunoperoxidase study of 20 cases and comparison with pulmonary adenocarcinomas.
J. Corson (1982)
10.1097/00000478-198706000-00005
Immunohistochemical Evaluation of Pleural Mesothelioma and Pulmonary Adenocarcinoma: A Bi-institutional Study of 47 Cases
C. Otis (1987)
The role of surgery in diffuse malignant mesothelioma of the pleura.
E. Butchart (1981)
10.1136/thx.33.1.26
Malignant mesothelioma of the pleura in Barrow-in-Furness.
J. Edge (1978)
10.1055/S-2007-1014139
Follow-up study of 100 malignant pleural mesotheliomas.
D. Krumhaar (1985)
Malignant mesothelioma--clinical and epidemiological features. A report of 80 cases.
K. Solomons (1984)
10.1002/1097-0142(19850415)55:8<1679::AID-CNCR2820550812>3.0.CO;2-C
Distinction of mesothelioma from adenocarcinoma. An immunohistochemical approach
H. Battifora (1985)
10.1093/AJCP/88.5.610
Immunohistochemical staining in malignant mesotheliomas.
J. G. Strickler (1987)
10.1016/S0022-5223(19)40189-X
Malignant pleural mesothelioma. Report of 19 cases.
J. Shearin (1976)
Pathology of human mesothelioma. Etiologic and diagnostic considerations.
V. Roggli (1987)
10.1097/00000421-198208000-00014
Chemotherapy for malignant mesothelioma: CAMEO
J. Jett (1982)
The radiology of thoracic malignant mesothelioma.
R. Wechsler (1984)
10.1378/CHEST.64.5.641
Mesothelioma following exposure to asbestos: a review of 72 cases.
M. Borow (1973)
10.1002/1097-0142(197909)44:3<914::AID-CNCR2820440319>3.0.CO;2-B
Malignant peritoneal mesothelioma following radiotherapy for seminoma of the testis
R. Stock (1979)
The outcome of patients with pleural effusion of indeterminate cause at thoracotomy.
Ryan Cj (1981)
10.1016/S0022-5223(19)41262-2
Localized mesothelioma of the pleura: benign and malignant variants.
N. Okike (1978)
10.1016/S0022-5223(19)38932-9
Surgical treatment of pleural mesothelioma.
P. McCormack (1982)
10.7326/0003-4819-96-6-746
Diffuse malignant mesothelioma. Prospective evaluation of 69 patients.
A. Chahinian (1982)
10.1080/00039896.1987.9935794
Screening of autopsy populations for previous occupational exposure to asbestos.
F. Mollo (1987)
Asbestos disease in Finland.
M. Huuskonen (1980)
Gallium-67 scanning in the evaluation of mesothelioma.
R. B. Wolk (1978)
10.1136/oem.17.4.260
Diffuse Pleural Mesothelioma and Asbestos Exposure in the North Western Cape Province
J. Wagner (1960)
10.2214/AJR.137.2.287
CT of malignant pleural mesothelioma.
E. Alexander (1981)
10.1002/1097-0142(197810)42:4<1692::AID-CNCR2820420406>3.0.CO;2-Y
The value of adriamycin in the treatment of diffuse malignant pleural mesothelioma
B. S. Yap (1978)
10.1016/S0003-4975(10)62906-2
Surgical management of malignant mesothelioma.
G. A. Delaria (1978)
10.1002/AJIM.4700090502
Recent trends in mesothelioma incidence in the United States.
R. Spirtas (1986)
10.1378/CHEST.60.6.564
Diffuse malignant mesothelioma of the pleura: a review of 37 cases.
H. Oels (1971)
Letter: Contact infection from live varicella vaccine recipients.
Y. Asano (1976)
10.1007/BF00915731
Monoclonal antibodies to human malignant mesothelioma
T. Anderson (2004)
10.1093/OXFORDJOURNALS.QJMED.A067473
The clinical aspects of mesothelioma.
P. Elmes (1976)
10.1016/S0140-6736(78)90145-9
THE HYGIENE STANDARD FOR CHRYSOTILE ASBESTOS
J. Peto (1978)
10.1136/jcp.39.9.961
New marker for mesothelioma: an immunoperoxidase study.
A. Donna (1986)
10.1136/thx.37.11.816
Pleural biopsy in the diagnosis of malignant mesothelioma.
A. Herbert (1982)
10.1002/1097-0142(197211)30:5<1216::AID-CNCR2820300511>3.0.CO;2-5
Malignant mesothelioma in childhood. Report of 13 cases
G. Grundy (1972)
10.1016/0013-9351(70)90026-5
Radiological features of diffuse mesothelioma.
A. Solomon (1970)
10.1097/00005792-197603000-00004
PLEURAL MESOTHELIOMAS—AN ANALYSIS OF 18 CASES AND REVIEW OF THE LITERATURE
D. A. Taryle (1976)
10.1111/J.1749-6632.1979.TB18711.X
MORTALITY EXPERIENCE OF INSULATION WORKERS IN THE UNITED STATES AND CANADA, 1943‐1976 *
I. Selikoff (1979)
10.1002/1097-0142(19840201)53:3<377::AID-CNCR2820530302>3.0.CO;2-B
Malignant mesothelioma. The university of minnesota experience
N. Vogelzang (1984)
10.1001/ARCHINTE.1987.00370120081015
Malignant mesothelioma with occupational and environmental asbestos exposure in an Illinois community hospital.
K. Wolf (1987)
10.1016/S0025-6196(12)60212-2
Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusion: analysis of 414 cases.
U. Prakash (1985)
10.1136/thx.31.1.15
Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients.
E. Butchart (1976)
The intermediate filament cytoskeleton of malignant mesotheliomas and its diagnostic significance.
G. Blobel (1985)
10.1111/j.1749-6632.1979.tb18779.x
CONTRIBUTION OF ELECTRON MICROSCOPY TO THE DIAGNOSIS OF PLEURAL MESOTHELIOMA *
P. Stoebner (1979)
10.1097/00000478-198601000-00005
Reactive and Neoplastic Serosal Tissue: A Light-Microscopic, Ultrastructural, and Immunocytochemical Study
J. W. Bolen (1986)



This paper is referenced by
10.1016/S0360-3016(02)04151-2
Intensity-modulated radiation therapy: a novel approach to the management of malignant pleural mesothelioma.
A. Ahamad (2003)
on Novel Therapies
Andrew R. Haas (2013)
10.1016/J.IJROBP.2005.04.015
Intensity-modulated radiation therapy for mesothelioma: impact of multileaf collimator leaf width and pencil beam size on planning quality and delivery efficiency.
X. Zhu (2005)
10.1007/978-3-642-72501-2_3
Der Stellenwert von Tumormarkerbestimmungen in der Diagnostik des malignen Pleuraergusses
W. Ebert (1993)
10.1056/NEJM199009063231008
Case 36-1990
H. Kazemi (1990)
10.1016/S0300-2896(15)31026-7
Hemotórax espontáneo masivo como manifestación inicial de mesotelioma pleural maligno
J. C. Martínez (1994)
10.1007/BF03165429
Ga-67 tumor scan in malignant diffuse mesothelioma —Comparison with CT and pathological findings—
S. Yoshida (1999)
10.1378/CHEST.93.2.433
Diffuse contralateral pulmonary metastases in malignant mesothelioma. An unusual radiographic presentation.
A. J. Uri (1988)
10.1007/BF00180050
Treatment of a patient with malignant mesothelioma with interferon-α2 based on in vitro sensitivity tests
V. Sexl (2004)
10.1016/S0360-3016(02)04150-0
Intensity-modulated radiotherapy following extrapleural pneumonectomy for the treatment of malignant mesothelioma: clinical implementation.
K. Forster (2003)
10.1080/10937404.2011.556052
Factors that Impact Susceptibility to Fiber-Induced Health Effects
J. Below (2011)
10.1007/BF02914452
Biopsies in patients with intrathoracic disease
G. Lillington (1990)
10.1007/978-3-642-72041-3_27
Nichtoperative Behandlung primärer und sekundärer Pleuratumoren
C. Manegold (1991)
10.1136/thoraxjnl-2013-204161
Mesothelioma risk after 40 years since first exposure to asbestos: a pooled analysis
A. Reid (2014)
MALIGNANT PLEURAL MESOTHELIOMA WITHOUT PRIOR ASBESTOS EXPOSURE - A RARE CASE REPORT
Ganesh Chandra Mohapatra (2015)
10.1007/s11307-010-0426-6
Current Evidence Base of FDG-PET/CT Imaging in the Clinical Management of Malignant Pleural Mesothelioma: Emerging Significance of Image Segmentation and Global Disease Assessment
S. Basu (2010)
10.1002/IJC.2910550331
in vitro effects of recombinant human interferon gamma on human mesothelioma cell lines
L. Zeng (1993)
10.1097/00130404-200311000-00008
Promising Early Local Control of Malignant Pleural Mesothelioma Following Postoperative Intensity Modulated Radiotherapy (IMRT) to the Chest
A. Ahamad (2003)
10.1016/0011-3840(93)90029-G
Malignant pleural mesothelioma.
H. Pass (2004)
10.1148/RADIOGRAPHICS.12.6.1439021
Imaging manifestations of pleural tumors.
M. Dynes (1992)
10.1378/CHEST.100.4.1003
Pleural fluid analysis in malignant mesothelioma. Prognostic implications.
A. Gottehrer (1991)
Study of lung asbestos content in a Spanish population
Velasco García (2014)
10.1245/s10434-006-9160-3
Extrapleural Pneumonectomy Is the Preferred Surgical Management in the Multimodality Therapy of Pleural Mesothelioma: Con Argument
R. Cameron (2006)
10.3109/14017439709041753
Long survival after extrapleural pneumonectomy for pleural malignant mesothelioma with metastasis to infradiaphragmatic lymph node.
H. Nomori (1997)
10.1053/SONC.2002.30228
The role of imaging in malignant pleural mesothelioma.
E. Marom (2002)
10.1016/j.ccm.2012.12.005
Malignant pleural mesothelioma: update on treatment options with a focus on novel therapies.
A. Haas (2013)
10.1002/(SICI)1096-9896(199912)189:4<581::AID-PATH464>3.0.CO;2-P
Value of morphometry, texture analysis, densitometry, and histometry in the differential diagnosis and prognosis of malignant mesothelioma
B. Weyn (1999)
10.1007/0-387-31056-8_38
Therapy for malignant pleural mesothelioma
H. Pass (2006)
Mesotelioma pleural. Similitudes clínico-radiológicas entre estirpes
C. Pérez-Guzmán (2008)
10.1007/s10552-009-9357-4
Ionizing radiation: a risk factor for mesothelioma
J. Goodman (2009)
10.1097/00001622-200303000-00003
The role of new imaging techniques in diagnosis and staging of malignant pleural mesothelioma
R. Eibel (2003)
10.1111/J.1749-6632.1991.TB24494.X
Asbestos‐Associated Pleural Mesothelioma in School Teachers: A Discussion of Four Cases a
D. Lilienfeld (1991)
See more
Semantic Scholar Logo Some data provided by SemanticScholar